3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
23
Breast Neoplasms
22
Carcinoma, Non-Small-Cell Lung
17
Rectal Neoplasms
13
Prostatic Neoplasms
13
Gliosarcoma
12
Lung Neoplasms
10
Head and Neck Neoplasms
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Neoplasms
9
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Adenocarcinoma Of Esophagus
8
Sarcoma
7
Neoplasm Metastasis
7
Central Nervous System Neoplasms
7
Pancreatic Neoplasms
6
Melanoma
6
Glioma
6
Carcinoma, Squamous Cell
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Burkitt Lymphoma
5
Oropharyngeal Neoplasms
4
Medulloblastoma
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Interventions
pembrolizumab
4
Cisplatin
4
Gemcitabine
3
Carboplatin
3
Docetaxel
2
Bupropion
2
tocilizumab
1
tislelizumab
1
spartalizumab
1
infigratinib
1
etoposide phosphate
1
cc-486
1
avelumab
1
Zoledronic Acid
1
Vorinostat
1
Varenicline
1
Tobacco Use Cessation Devices
1
Radiotherapy, Intensity-Modulated
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Oral Hygiene
1
Nivolumab
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Ifosfamide
1
Gene Expression Profiling
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Neoplasms
×
Radiation
×
Clear all
No trials found.